Abdulla Al Amoodi
Abdulla Al Amoodi publishes mostly in Endocrinology, Diabetes and Metabolism, Infectious Diseases and Cardiology and Cardiovascular Medicine, on topics such as COVID-19 Clinical Research Studies, Long-Term Effects of COVID-19 and Pharmacological Receptor Mechanisms and Effects.
- World rank
- #6,977,385 of 7,710,434 ranked researchers
- Rank in United Arab Emirates
- #5,991 of 6,273
- Works
- 21
- Citations
- 88
- Citations per work
- 4.2
What does Abdulla Al Amoodi research?
Abdulla Al Amoodi's work is mostly in Medicine (41%), Biochemistry, Genetics and Molecular Biology (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else1151.7%
- Health Sciences940.9%
- Medicine940.9%
- Life Sciences27.4%
- 1Endocrinology, Diabetes and Metabolism9% of their works
- 2Infectious Diseases9% of their works
- 3Cardiology and Cardiovascular Medicine9% of their works
- 4Neurology7% of their works
- 5Molecular Biology7% of their works
- 6Pulmonary and Respiratory Medicine6% of their works
Research topics
- COVID-19 Clinical Research Studies
- Long-Term Effects of COVID-19
- Pharmacological Receptor Mechanisms and Effects
- Atrial Fibrillation Management and Outcomes
- Heart Failure Treatment and Management
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Autoimmune and Inflammatory Disorders Research
- COVID-19 and healthcare impacts
Which keywords describe Abdulla Al Amoodi's research?
The keywords of their largest research topics: Epidemiology, Pandemic, Clinical Characteristics, Guidelines, Mortality, SARS-CoV-2, Neurologic Manifestations and Post-acute COVID-19 Syndrome.
- Sigma-1 Receptor
- Insulin Therapy
- Hemophagocytic Lymphohistiocytosis
- Diagnosis
- Cancer
- Atrial Fibrillation
- Post-acute COVID-19 Syndrome
- SARS-CoV-2
- Guidelines
- Pandemic
- Epidemiology
- Clinical Characteristics
- Mortality
- Neurologic Manifestations
- Anticoagulant Therapy
- COVID-19
- Chaperone
- Heart Failure
- Hyperglycemia
- Juvenile Idiopathic Arthritis
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Epidemiology62 topics
- Pandemic62 topics
- Clinical Characteristics41 topic
- Guidelines42 topics
- Mortality42 topics
- SARS-CoV-241 topic
- Neurologic Manifestations31 topic
- Post-acute COVID-19 Syndrome31 topic
- Anticoagulant Therapy21 topic
- Atrial Fibrillation21 topic
- COVID-1921 topic
- Cancer21 topic
- Chaperone21 topic
- Diagnosis21 topic
- Heart Failure21 topic
- Hemophagocytic Lymphohistiocytosis21 topic
- Hyperglycemia21 topic
- Insulin Therapy21 topic
- Juvenile Idiopathic Arthritis21 topic
- Sigma-1 Receptor21 topic
Where does Abdulla Al Amoodi work?
Abdulla Al Amoodi's main affiliation in the publication record is Abu Dhabi Health Services, United Arab Emirates.
How many publications and citations does Abdulla Al Amoodi have?
OpenAlex counts 21 works and 88 citations for Abdulla Al Amoodi, an h-index of 6, ranking #6,977,385 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Abdulla Al Amoodi. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.